Research shows that chronic kidney disease affects men’s hearts and women’s bones in opposite ways. In a 2026 study of 23 mice with kidney disease, females developed 28% more porous bones when eating a high-phosphate diet, while males developed 28% larger heart cells instead. Female mice produced 770% more of a hormone called FGF23 compared to males, suggesting their bodies respond much more strongly to phosphate overload. According to Gram Research analysis, these findings suggest that men and women with kidney disease may need different treatment approaches focused on their specific vulnerabilities.
When kidneys stop working properly, the body struggles to control phosphate levels, a mineral that can damage both bones and the heart. According to Gram Research analysis, a new study found that men and women respond very differently to this problem. In female mice with kidney disease, bones became weaker and more fragile. In male mice, the heart grew larger and thicker instead. This discovery helps explain why kidney disease affects men and women in different ways and could lead to better treatments tailored to each sex.
Key Statistics
A 2026 experimental study of 23 mice found that female mice with kidney disease produced 770% more FGF23 hormone than males when fed a high-phosphate diet, indicating a much stronger biological response to phosphate overload.
Female mice with kidney disease developed 28% more porous bones after 10 weeks on a high-phosphate diet, while male mice developed 28% larger heart cells, showing opposite organ system responses between sexes.
In a 2026 mouse study of chronic kidney disease, parathyroid hormone increased 201% in females versus 118% in males on a high-phosphate diet, demonstrating sex-dependent differences in mineral metabolism hormones.
The Quick Take
- What they studied: How kidney disease affects bones and hearts differently in males versus females when eating a high-phosphate diet
- Who participated: 23 adult mice (both male and female) that had 5/6 of their kidney tissue removed to mimic chronic kidney disease, then fed either normal or high-phosphate diets for 10 weeks
- Key finding: Female mice developed much worse bone problems with 28% more porous bones, while male mice developed enlarged hearts with 28% larger heart cells. Female mice showed 770% higher levels of a hormone called FGF23 compared to males
- What it means for you: This research suggests that women with kidney disease may need different bone-protecting treatments than men, who may need more heart monitoring. However, this was a mouse study, so results may not directly apply to humans yet
The Research Details
Researchers used laboratory mice to study how chronic kidney disease affects the body differently in males and females. They removed most of one kidney in each mouse to create kidney disease similar to what humans experience. Half the mice ate normal food with regular phosphate levels, while the other half ate food with three times more phosphate. After 10 weeks, the researchers measured changes in bones, hearts, and blood chemistry.
This type of study is called an experimental animal model. Scientists use mice because their bodies process minerals similarly to humans, and researchers can carefully control exactly what they eat and measure precise changes. The study included both sexes to specifically look for differences in how males and females respond to the same kidney disease and diet.
Understanding sex differences in kidney disease is important because kidney disease is more common in women, but causes more heart problems in men. By studying how males and females respond differently to phosphate overload, researchers can develop treatments that work better for each group. This approach, called precision medicine, tailors treatments to individual characteristics rather than using one-size-fits-all approaches.
This was a controlled laboratory study with a relatively small sample size of 23 mice. The researchers carefully measured multiple markers of bone and heart health, which strengthens the findings. However, because this is an animal study, results may not directly transfer to humans. The study was published in a peer-reviewed journal, meaning other experts reviewed the work before publication. The findings are preliminary and would need human studies to confirm whether the same sex differences occur in people with kidney disease.
What the Results Show
When mice ate a high-phosphate diet, their bodies produced much more of a hormone called FGF23, which helps kidneys remove extra phosphate. Female mice produced 770% more of this hormone than males eating the same diet, showing that females respond much more strongly to phosphate overload.
Despite this strong response, female mice developed serious bone problems. Their bones became 28% more porous, meaning they had more holes and weak spots, similar to osteoporosis in humans. Their bones also showed signs of breaking down and rebuilding too quickly, which weakens the skeleton over time.
Male mice showed a different pattern. Instead of bone problems, their hearts grew larger, with heart cells increasing by 28% in size. This condition, called cardiac hypertrophy, can eventually lead to heart failure if it continues. Interestingly, neither group developed calcium deposits in blood vessels, which often occurs in advanced kidney disease.
Blood phosphate levels stayed normal in both groups, even though the mice ate three times more phosphate. This suggests that the FGF23 hormone was still working well enough to remove the extra phosphate through urine, indicating these mice had early-stage kidney disease rather than advanced disease. Parathyroid hormone, another mineral-regulating hormone, also increased in both sexes but more dramatically in females (201% increase versus 118% in males). A protein called osteopontin, which is involved in bone breakdown, increased in both groups but again was more pronounced in females.
Previous research has shown that kidney disease affects men and women differently, but the specific mechanisms were unclear. This study provides new evidence that the sex difference may start at the hormone level, with females mounting a much stronger FGF23 response. The finding that females develop bone problems while males develop heart problems aligns with clinical observations that kidney disease causes more cardiovascular deaths in men but more bone fractures in women.
This study used mice, not humans, so the results may not directly apply to people with kidney disease. The sample size was small (23 mice total), which limits how confident we can be in the findings. The study only lasted 10 weeks, so we don’t know what happens with longer-term kidney disease. The mice were all the same genetic strain, so results might differ in people with different genetic backgrounds. No vascular calcifications developed in any mice, which is a common complication in human kidney disease, suggesting these mice may not fully replicate the human disease.
The Bottom Line
Based on this research, women with chronic kidney disease should have their bone health monitored closely and may benefit from bone-strengthening treatments. Men with kidney disease should have regular heart monitoring and may need treatments to prevent heart enlargement. However, these recommendations are preliminary and based on animal research. Anyone with kidney disease should follow their doctor’s specific treatment plan, which may include phosphate-restricted diets, medications, and regular monitoring. Confidence level: Low to moderate, as this is animal research that needs human confirmation.
This research is most relevant to people with chronic kidney disease, their doctors, and researchers developing new kidney disease treatments. Women with kidney disease should be especially interested in bone health implications. Men with kidney disease should pay attention to heart health monitoring. Healthcare providers treating kidney disease patients should consider these sex-specific differences when planning treatment. People at risk for kidney disease (those with diabetes or high blood pressure) may want to discuss prevention strategies with their doctors.
In mice, bone and heart changes developed over 10 weeks. In humans, these changes typically develop over months to years depending on how severe the kidney disease is. Bone loss may become noticeable within 6 to 12 months of untreated kidney disease, while heart enlargement can take longer to develop. Starting treatment early, including phosphate-restricted diets and appropriate medications, may slow or prevent these changes.
Frequently Asked Questions
Does kidney disease affect men and women differently?
Yes, research shows kidney disease affects men and women differently. A 2026 study found that women develop worse bone problems with increased porosity, while men develop enlarged hearts. Women also produce much higher levels of FGF23 hormone in response to phosphate overload.
What happens to bones when you have chronic kidney disease?
In kidney disease, bones can become weaker and more porous as hormones like FGF23 and PTH increase. A 2026 study showed female mice developed 28% more porous bones on a high-phosphate diet, increasing fracture risk similar to osteoporosis.
Can kidney disease cause heart problems?
Yes, kidney disease can cause the heart to enlarge and thicken. A 2026 study found male mice with kidney disease developed 28% larger heart cells, a condition called cardiac hypertrophy that can eventually lead to heart failure.
Should I restrict phosphate if I have kidney disease?
A phosphate-restricted diet may help manage kidney disease, especially as it progresses. A 2026 study showed that high-phosphate diets triggered much stronger hormone responses in mice with kidney disease, suggesting dietary phosphate control could be beneficial.
What is FGF23 and why does it matter in kidney disease?
FGF23 is a hormone that helps kidneys remove extra phosphate through urine. In kidney disease, FGF23 levels rise dramatically. A 2026 study found females produced 770% more FGF23 than males, showing how strongly the body tries to compensate for kidney dysfunction.
Want to Apply This Research?
- Track weekly phosphate intake by logging foods high in phosphate (processed meats, dairy, nuts, seeds) and monitor bone health markers through periodic blood tests and bone density scans if recommended by your doctor
- Set a daily reminder to log phosphate-containing foods and create a meal plan focused on phosphate-restricted options recommended by a renal dietitian, with the app providing phosphate content for common foods
- Use the app to track trends in phosphate intake over months, record doctor visit notes about bone and heart health markers, and set quarterly reminders for recommended bone density and heart function tests
This research was conducted in laboratory mice and has not been tested in humans. While the findings are interesting, they are preliminary and should not be used to make medical decisions without consulting your healthcare provider. If you have chronic kidney disease or are at risk for kidney disease, work with your doctor to develop a personalized treatment plan. This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.